Vanguard Group’s Scienture Holdings SCNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$309K Buy
24,246
+17,965
+286% +$316K ﹤0.01% 4030
2025
Q3
$133K Buy
6,281
+5,698
+977% +$203K ﹤0.01% 4188
2025
Q2
$15.1K Hold
583
– – ﹤0.01% 4256
2025
Q1
$21K Buy
583
+1
+0.2% +$78 ﹤0.01% 4244
2024
Q4
$88K Hold
582
– – ﹤0.01% 4172
2024
Q3
$107K Hold
582
– – ﹤0.01% 4191
2024
Q2
$163K Hold
582
– – ﹤0.01% 4187
2024
Q1
$149K Buy
+582
New +$144K ﹤0.01% 4208
2023
Q2
– Sell
-106
Closed -$11.7K – 4574
2023
Q1
$11.7K Sell
106
-317
-75% -$45.5K ﹤0.01% 4541
2022
Q4
$63.9K Sell
423
-55
-12% -$14.7K ﹤0.01% 4427
2022
Q3
$203K Buy
478
+23
+5% +$12.2K ﹤0.01% 4413
2022
Q2
$277K Hold
455
– – ﹤0.01% 4419
2022
Q1
$473K Hold
455
– – ﹤0.01% 4411
2021
Q4
$403K Hold
455
– – ﹤0.01% 4466
2021
Q3
$841K Buy
455
+85
+23% +$165K ﹤0.01% 4284
2021
Q2
$613K Buy
+370
New +$592K ﹤0.01% 4237

Other funds holding SCNX

Vanguard Group's SCNX Position: Q4 2025 in Review

Vanguard Group increased its Scienture Holdings (SCNX) stake by 286% in Q4 2025, buying an estimated $316K and bringing the position to 24,246 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Vanguard Group first reported a position in SCNX in Q2 2021 and has held it in 16 quarters since. The position peaked at $841K in Q3 2021. 12 funds tracked by Wall St. Rank hold SCNX as of Q4 2025.

  • Vanguard Group held 24,246 shares of Scienture Holdings worth $309K as of Q4 2025.
  • Vanguard Group bought 17,965 Scienture Holdings shares in Q4 2025, an estimated $316K.
  • Scienture Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4030 holding.
  • Vanguard Group first reported a position in Scienture Holdings in Q2 2021 and has held it in 16 quarters since.
  • Vanguard Group's Scienture Holdings position peaked at $841K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Scienture Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.